Effects of melanin upon susceptibility of Cryptococcus to antifungals

被引:96
作者
Ikeda, R
Sugita, T
Jacobson, ES
Shinoda, T
机构
[1] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo 2048588, Japan
[2] McGuire Dept Vet Affairs Med Ctr, Res Serv, Richmond, VA 23249 USA
[3] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA
关键词
Cryptococcus neoformans; Cryptococcus albidus; melanin; susceptibility;
D O I
10.1111/j.1348-0421.2003.tb03395.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Melanin is a recognized virulence factor in Cryptococcus neoformans; several pathogenetic mechanisms have been suggested. We studied melanin as an antifungal resistance factor. The growth of laccase-active strains of C. neoformans and C albidus in L-DOPA resulted in the production of black pigment. The formal minimal inhibitory concentrations (MICs) of amphotericin B and fluconazole were not changed by melanization. However, when we examined those wells which contained inhibited cells, we found live cells only in wells containing melanized C. neoformans. In contrast, melanization did not protect C. albidus from killing by amphotericin B. In an amphotericin B time-kill study of C. neoformans, significantly more melanized cells than non-melanized survived for the first few hours. Fluorescence microscopy and flow cytometry analyses showed that fewer melanized cells were stained with the fluorescent dye MitoRed. Incubation of MitoRed (the model) or amphotericin B with melanin extracted from C. neoformans decreased the free concentrations of these substances. Fluconazole, in contrast, was not removed from solution by melanin. This suggests that neoformans cryptococcal melanin deposited amphotericin B in the cell wall binds, reducing its effective concentrations.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 28 条
[1]   Fungal melanins: a review [J].
Butler, MJ ;
Day, AW .
CANADIAN JOURNAL OF MICROBIOLOGY, 1998, 44 (12) :1115-1136
[2]   Melanin and virulence in Cryptococcus neoformans [J].
Casadevall, A ;
Rosas, AL ;
Nosanchuk, JD .
CURRENT OPINION IN MICROBIOLOGY, 2000, 3 (04) :354-358
[3]  
CASADEVALL A, 1998, CRYPTOCOCCUS NEOFORM, P145
[4]   Melanin as a potential cryptococcal defence against microbicidal proteins [J].
Doering, TL ;
Nosanchuk, JD ;
Roberts, WK ;
Casadevall, A .
MEDICAL MYCOLOGY, 1999, 37 (03) :175-181
[5]   Chromoblastomycosis [J].
Elgart, GW .
DERMATOLOGIC CLINICS, 1996, 14 (01) :77-&
[6]  
Hamilton AJ, 2002, J MED MICROBIOL, V51, P189, DOI 10.1099/0022-1317-51-3-189
[7]   Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans [J].
Ikeda, R ;
Sugita, T ;
Jacobson, ES ;
Shinoda, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1214-1218
[8]   Pathogenic roles for fungal melanins [J].
Jacobson, ES .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (04) :708-+
[9]   Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia [J].
Johnson, LB ;
Bradley, SF ;
Kauffman, CA .
MYCOSES, 1998, 41 (7-8) :277-280
[10]   Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods [J].
Klepser, ME ;
Ernst, EJ ;
Lewis, RE ;
Ernst, ME ;
Pfaller, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1207-1212